2024 Annual Meeting | N2 - Neuroscience in the Clinic: Neuromodulation: From Bench to Bedside
Program Materials Program Evaluations
01:00 PM - 01:03 PM MDT | Introduction |
Introduction
Joshua M. Shulman, MD, PhD, FAAN |
01:03 PM - 01:28 PM MDT | Speaker |
Blood-brain Barrier: Friend and Foe—Towards Targeted, Noninvasive Study and Repair of Nervous Systems
Viviana Gradinaru, PhD |
01:28 PM - 01:53 PM MDT | Speaker |
Ultrasonic Drug Uncaging for Noninvasive Targeted Neuro-pharmacology
Raag Airan |
01:53 PM - 02:18 PM MDT | Speaker |
Circuit-Inspired Strategies to Improve Treatments for Parkinson’s Disease
Aryn Gittis |
02:18 PM - 02:30 PM MDT | Abstract |
001 - Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease
Amber D. Van Laar, MD |
02:30 PM - 02:42 PM MDT | Abstract |
002 - Cognito’s non-invasive medical device demonstrates durable effects on activities of daily living through OVERTURE open-label extension study.
Ralph Z. Kern, MD |
02:42 PM - 03:00 PM MDT | Discussion |
Discussion and Panel Q&A
Joshua M. Shulman, MD, PhD, FAAN, Viviana Gradinaru, PhD, Raag Airan, Aryn Gittis |
Joshua M. Shulman, MD, PhD, FAAN | Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health. |
Viviana Gradinaru, PhD | Viviana Gradinaru, PhD has nothing to disclose. |
Raag Airan | No disclosure on file |
Aryn Gittis | No disclosure on file |
Ralph Z. Kern, MD | Dr. Kern has received personal compensation for serving as an employee of Cognito Therapeutics. |
ZD Kuang | No disclosure on file |
Mihaly Hajos, PhD | Prof. Hajos has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. Prof. Hajos has stock in Cognito Therapeuitcs. Prof. Hajos has stock in Biogen. Prof. Hajos has stock in Pfizer. Prof. Hajos has received intellectual property interests from a discovery or technology relating to health care. |
Alex Konisky | No disclosure on file |
Alyssa Boasso | No disclosure on file |
Evan Hempel | No disclosure on file |
Brent Vaughan | No disclosure on file |
Chandran Seshagiri | No disclosure on file |
Zach Malchano | Mr. Malchano has received personal compensation for serving as an employee of Cognito Therapeutics, Inc.. Mr. Malchano has received stock or an ownership interest from Cognito Therapeutics. |
Suzanne Hendrix, PhD | Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has stock in Pentara. |
Khalil Saikali | No disclosure on file |
Joseph Massey | No disclosure on file |
Ramesh Arjunji | No disclosure on file |
Amber D. Van Laar, MD | Dr. Van Laar has received personal compensation for serving as an employee of Asklepios Biopharmaceutical. The institution of an immediate family member of Dr. Van Laar has received research support from Asklepios BioPharmaceutical Inc. |
Chadwick W. Christine, MD, FAAN | The institution of Dr. Christine has received research support from Neurocrine Biosciences. The institution of Dr. Christine has received research support from Brain Neurotherapy Bio, Inc. The institution of Dr. Christine has received research support from Michael J Fox Foundation for Parkinson's Research. The institution of Dr. Christine has received research support from Annovis Bio. The institution of Dr. Christine has received research support from Aspen Neurosciences. |
Aristide Merola, MD, PhD | Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. |
Nicolás Phielipp, MD | No disclosure on file |
Bradley Elder | No disclosure on file |
Paul Larson | No disclosure on file |
Waldy San Sebastian | No disclosure on file |
Adrian Kells | No disclosure on file |
Massimo Fiandaca | No disclosure on file |
Krystof Bankiewicz | No disclosure on file |